Scientific platform one.bio has officially emerged from stealth with a dual-pronged launch designed to overhaul how the food industry approaches fibre fortification. The company has unveiled its proprietary fibre discovery technology, its first clinically validated ingredient (one.bio 01), and a demonstration consumer brand, GoodVice.
The platform is built on a radical premise: that chronic disease is not a failure of the human body, but a response to the systematic removal of essential biological signals—specifically diverse fibre structures—from the modern food supply.
The 'Glycopedia': Mapping Structure to Function
Central to one.bio’s technology is the Glycopedia, a novel knowledgebase that maps specific fibre structures to microbial fermentation pathways and downstream biological outcomes.
Moving beyond the generic "eat more fibre" guidance, one.bio argues that fibres are not interchangeable. Different structures signal distinct biological functions, such as strengthening the gut barrier, reducing inflammation, or regulating glucose. The platform identifies which fibres trigger specific metabolic responses, allowing for precision formulation.
Matt Barnard, Co-founder and CEO of one.bio, explained the philosophy:
"For nearly all of human history, fibre wasn't optional. It regulated metabolism, signalled satiety, calibrated the immune system and governed inflammation... In the last 70 years, those signals were removed. The body is still listening. It hears silence."
Ingredient Innovation: one.bio 01
The company’s first commercial output, one.bio 01, is an oat fibre designed to solve the sensory trade-offs that have historically hindered high-fibre product acceptance. Available for commercial use in February, the ingredient is described as flavourless, odourless, colourless, and fully water-soluble.
Clinical Validation (Study NCT06739941): In a 14-day clinical study with 63 adults, the ingredient demonstrated significant functional benefits without the digestive distress often associated with fibre supplements like inulin or FOS.
Metabolic Control: Participants recorded reduced blood sugar spikes and improved glucose stability.
Cognitive Clarity: Improvements in concentration and mental health were noted in participants with elevated baseline symptoms.
Tolerance: Improved digestive comfort even at high intake levels.
Commercial Strategy and GoodVice
To demonstrate the "invisibility" of its technology, one.bio has launched GoodVice, a consumer food brand acting as a proof-of-concept for the platform.
Matt Amicucci, PhD, Co-founder and Chief Science Officer, emphasised the B2B potential: "Invisibility is the breakthrough. It allows brands to turn guilty pleasures into metabolic solutions. If people have to fight their food, it doesn't scale."
By offering an ingredient that disappears into beverages, baked goods, and sauces without altering texture or taste, one.bio aims to allow manufacturers to restore historical fibre levels (aiming closer to the ancestral 80-120g/day vs. the modern 12g/day) without demanding radical dietary behaviour changes from consumers.
.png)
RaFoods Launches Living Nutrition Fund to Support Health Across America
Nestlé Launches Compleat Paediatric Oral Blends in European Markets
Little Spoon Expands into Newborn Nutrition with Transparency-Led Formula Launch
